For over a century, the pupillary examination has rested on a simple ritual: a clinician, a penlight, and a judgement rendered in an instant — is the pupil brisk, sluggish, or unresponsive? It is among the most venerable of bedside assessments, and also among the least dependable. When clinicians examine the same patient, their agreement on whether the pupils are unequal falls below fifty percent, and the unaided eye is wholly incapable of detecting the subtle, incremental changes that so often precede deterioration.

Automated pupillometry offers a more rigorous alternative. A calibrated flash of light is delivered, the pupil’s response recorded in fine detail, and the result distilled into a single value — the Neurological Pupil index (NPi), scaled from 0 to 5, with anything below 3 flagged as abnormal. In shining light and measuring the constriction that follows, the device tests the full pupillary light reflex — the afferent limb carried by the optic nerve (cranial nerve II) that senses the light, and the efferent limb carried by the parasympathetic fibres of the oculomotor nerve (cranial nerve III) that drives constriction. Its warning power rests chiefly on the efferent (CN III) pathway, which is exquisitely sensitive to rising intracranial pressure and is compressed early as the brain begins to herniate. A gradually falling NPi can therefore signal catastrophe hours before the dreaded “blown pupil” appears. Measured every four to six hours, it now helps anticipate dangerous swelling after stroke, head injury, and surgery, and — via the 2025 NPi-Connect system — feeds straight into the medical record as a trackable vital sign independent of who holds the light.

The supporting evidence continues to accumulate. Automated pupillometry is now employed to anticipate dangerous brain swelling in stroke, with measurements taken every four to six hours to follow the trajectory rather than a single isolated reading. The same principle has proven valuable following traumatic brain injury and neurosurgery, where a falling NPi identifies patients on the verge of decline. In early 2025, a system known as NPi-Connect began transmitting these readings directly into the electronic medical record, establishing the NPi as a properly documented, trackable vital sign that no longer depends upon the individual performing the examination.

The limitations, however, deserve candid acknowledgement. Commonly used sedatives and analgesics — opioids and dexmedetomidine among them — blunt the pupillary response, and recent work demonstrates that the depth of sedation can meaningfully distort the reading. Iris pigmentation, prior ocular surgery, direct orbital trauma, and certain neuromuscular conditions may all degrade its accuracy, and the measurement interrogates only a single nerve pathway, offering no insight into the wider brain. The four-to-six-hour intervals between readings likewise leave unmonitored windows.

The most compelling horizon lies in estimating the pressure within the skull without breaching it at all. Emerging systems infer that pressure from the faint pulsatile expansion of the skull, from gentle microwave or near-infrared signals, or from ultrasound of the sheath surrounding the optic nerve. One such approach now falls within roughly 3 mmHg of the true value, achieving accuracy to within a few points in approximately 72 percent of cases. Combining these signals — the pupillary index, a non-invasive pressure estimate, and the optic nerve measurement — offers a credible route toward sparing many patients an invasive monitor placed through the skull. For the present, the invasive monitor retains its primacy, and the prudent posture is to regard pupillometry as a valuable early-warning companion rather than the sole arbiter of a swelling brain.